# Kerecis Omega3 Wound Plus SOC vs. SOC Alone in Treating Severe Diabetic Foot Ulcers and Forefoot Amputations

> **NCT04257370** · NA · COMPLETED · sponsor: **Kerecis Ltd.** · enrollment: 260 (actual)

## Conditions studied

- Diabetic Foot Ulcer
- Dehiscence of Amputation Stump
- Amputation

## Interventions

- **DEVICE:** Kerecis™ Omega3 Wound
- **OTHER:** Standard of care

## Key facts

- **NCT ID:** NCT04257370
- **Lead sponsor:** Kerecis Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-09
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-11-25
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2023-02-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04257370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04257370, "Kerecis Omega3 Wound Plus SOC vs. SOC Alone in Treating Severe Diabetic Foot Ulcers and Forefoot Amputations". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04257370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*